ArticleOncotarget2018

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic.

Vikas Dembla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.